VC-backed Galecto raises $85m for IPO

Galecto, a Danish developer of treatments for fibrotic and related diseases, including cancer, has raised about $85 million for its IPO after pricing its over 5.6 million shares at $15 per share.

To read this article, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to read this article and more for free.

Share this